Introducing the Anti-GaHV-2 MDV008/pp24 Polyclonal Antibody – the cutting-edge solution for your biotech research needs.
This powerful antibody is specifically designed to target the GaHV-2 MDV008/pp24 protein, a key player in the replication of the highly pathogenic Marek’s Disease Virus (MDV). By binding to this protein, the Anti-GaHV-2 MDV008/pp24 Polyclonal Antibody effectively blocks its function, inhibiting the virus’s ability to spread and cause harm.
With its high specificity and sensitivity, this antibody is an essential tool for studying the molecular mechanisms of MDV infection and developing new treatments for this devastating disease. Its unique ability to target the GaHV-2 MDV008/pp24 protein makes it a valuable asset for both basic research and drug discovery.
But the Anti-GaHV-2 MDV008/pp24 Polyclonal Antibody is not just limited to MDV studies. Its broad cross-reactivity with other GaHV-2 strains and related viruses also makes it a valuable tool for studying other diseases caused by these viruses, such as avian leukosis and reticuloendotheliosis.
In addition to its wide range of applications, this antibody has been extensively tested and validated for use in various experimental techniques, including Western blot, immunofluorescence, and immunohistochemistry. Its outstanding performance in these assays ensures reliable and reproducible results, making it a top choice for researchers in the biotech industry.
Don’t settle for generic antibodies that may not provide the specificity and sensitivity you need for your research. Choose the Anti-GaHV-2 MDV008/pp24 Polyclonal Antibody for its unparalleled ability to target the GaHV-2 MDV008/pp24 protein, its wide range of applications, and its proven performance in various experimental techniques. Take your biotech research to the next level with this innovative antibody. Order now and unlock the full potential of your research.
There are no reviews yet.